Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

October 6, 2020
Open Access

Efficacy of Dose-Titrated Glucagon Infusions in the Management of Congenital Hyperinsulinism: A Case Series

Frontiers in Endocrinology
Maria Salomon-EstebanezIndraneel Banerjee
October 9, 2020
Case Report

Detection of hepatocyte nuclear factor 4A(HNF4A) gene variant as the cause for congenital hyperinsulinism leads to revision of the diagnosis of the mother

Journal of Pediatric Endocrinology & Metabolism : JPEM
Elpis-Athina VlachopapadopoulouStefanos Michalacos
June 26, 2020
Open Access

Longitudinal Auxological recovery in a cohort of children with Hyperinsulinaemic Hypoglycaemia

Orphanet Journal of Rare Diseases
Chris WorthIndraneel Banerjee
August 28, 2020
Open Access

Efficacy and safety of octreotide treatment for diazoxide-unresponsive congenital hyperinsulinism in China

Pediatric Investigation
Bingyan CaoChunxiu Gong
October 5, 2020
Open Access

Neuro Developmental Consequences of Neonatal Hypoglycemia

Orhideja StomnaroskaDragan Danilovski
July 17, 2020
Case Report
Open Access

A Novel HNF4A Mutation Causing Three Phenotypic Forms of Glucose Dysregulation in a Family

Frontiers in Pediatrics
Suresh ChandranFabian Yap
August 21, 2020
Case Report
Open Access

Congenital hyperinsulinism in three patients from the same family. Expanding the genotype of this disease

Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)
Katia Herrera AzabacheAna Pilar Nso-Roca
September 16, 2020
Open Access

Diagnosis of congenital Hyperinsulinism can occur not only in infancy but also in later age: a new flow chart from a single center experience

Italian Journal of Pediatrics
Alberto CasertanoAdriana Franzese
December 23, 2020
Open Access

Comparative morphofunctional analysis of the state of fetoplacental complex in diabetes mellitus (literature review)

Problemy e̊ndokrinologii
Olga R GrigoryanElena N Andreeva
May 27, 2020

Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT

Clinical Nuclear Medicine
Kerstin MichalskiJuri Ruf
June 3, 2020
Open Access

Sirolimus therapy and follow-up in a patient with severe congenital hyperinsulinism following subtotal pancreatectomy

Journal of Clinical Research in Pediatric Endocrinology
Qiong ChenHaiyan Wei
December 29, 2020

Gut Microbiome Profile After Pancreatectomy in Infants With Congenital Hyperinsulinism

Mary Ellen VajraveluDiva D De Leon
November 17, 2020
Open Access

Possible New Strategies for the Treatment of Congenital Hyperinsulinism

Frontiers in Endocrinology
Jelena SikimicGisela Drews
January 12, 2021
Open Access

Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism

Frontiers in Endocrinology
Marcia RoeperThomas Meissner
September 3, 2020
Open Access

Evaluating Inositol phospholipid interactions with Inward Rectifier Potassium Channels and characterising their role in Disease

BioRxiv : the Preprint Server for Biology
T. PipatpolkaiPhillip James Stansfeld
June 17, 2020
Case Report
Open Access

Congenital hyperinsulinsim: case report and review of literature

The Pan African Medical Journal
Brahim El HasbaouiAomar Agadr
December 29, 2020

The use of long-acting somatostatin analogs in congenital hyperinsulinism

Problemy e̊ndokrinologii
E E NovokreshhennyxMaria A Melikyan

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Adult Polyglucosan Body Disease

Adult polyglucosan body disease (APBD) is a rare autosomal recessive disease characterized by defects in the glycogen brancher enzyme 1 (GBE1) gene. Discover the latest research on APBD here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.


Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research.

Bullous Pemphigoid

Bullous pemphigoid is a chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. Discover the latest research on bullous pemphigoid here.

CLOVES Syndrome

Congenital, Lipomatous, Overgrowth, Vascular Malformations, Epidermal Nevi and Spinal/Skeletal Anomalies and/or Scoliosis (CLOVES) syndrome is a rare genetic disorder caused by mutations in the PIK3CA gene. Symptoms include blood vessel abnormalities, small tissue tumors, skin legions and spinal abnormalities. Here is the latest research.

© 2021 Meta ULC. All rights reserved